MEDCAP AB SK-40
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium… Read more
MEDCAP AB SK-40 (61MA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, MEDCAP AB SK-40 (61MA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MEDCAP AB SK-40 - Net Assets Trend (None–None)
This chart illustrates how MEDCAP AB SK-40's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDCAP AB SK-40 (None–None)
The table below shows the annual net assets of MEDCAP AB SK-40 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MEDCAP AB SK-40's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MEDCAP AB SK-40 Competitors by Market Cap
The table below lists competitors of MEDCAP AB SK-40 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Financial Institutions Inc
NASDAQ:FISI
|
$533.15 Million |
|
Beijing Topnew Info And Tech Co Ltd
SHE:300895
|
$533.19 Million |
|
Semrush Holdings Inc
NYSE:SEMR
|
$533.34 Million |
|
Dongsuh
KO:026960
|
$533.53 Million |
|
Red Star Macalline Group Corp Ltd Class A
SHG:601828
|
$533.09 Million |
|
Carlsberg Brewery Malaysia Bhd
KLSE:2836
|
$533.05 Million |
|
FORWARD AIR CORP. DL-01
F:FA2
|
$532.93 Million |
|
Zhuhai Enpower Electric Co Ltd
SHE:300681
|
$532.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDCAP AB SK-40's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MEDCAP AB SK-40's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDCAP AB SK-40 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MEDCAP AB SK-40's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDCAP AB SK-40 (61MA) | €- | N/A | N/A | $533.12 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |